Jabil healthcare announces the launch of the qfinity™ autoinjector platform, a reusable drug delivery device with broad applicability

St. petersburg, fla.--(business wire)--jabil healthcare, a division of jabil inc. (nyse: jbl), announces the launch of the qfinity™ autoinjector platform, a simple, reusable and modular solution for subcutaneous (sc) drug self-administration, at a lower cost than market alternatives — supporting the emerging prioritization of sustainable drug delivery within the pharmaceutical industry. jabil healthcare has been a trusted partner with the world's leading healthcare brands for over 30 years, and
JBL Ratings Summary
JBL Quant Ranking